Kaya H, Keung YK, Case D, Cruz JM, Perry JJ, Radford JE, Hurd DD. Efficacy and safety of monoclonal anti-CD20 antibody (rituximab) for the treatment of patients with recurrent low-grade non-Hodgkin's lymphoma after high-dose chemotherapy and autologous hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2002; 8(10):544-9.